Philadelphia, PA, United States of America

Michael Klichinsky

USPTO Granted Patents = 11 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2021-2023

Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Michael Klichinsky

Introduction

Michael Klichinsky is a prominent inventor based in Philadelphia, PA, known for his significant contributions to the field of immunotherapy. With a total of 11 patents to his name, Klichinsky has made remarkable strides in developing methods to enhance the immune response against cancer.

Latest Patents

Among his latest patents is a method of increasing tumor-killing activity of macrophages or monocytes comprising chimeric antigen receptors (CARs). This patent focuses on immune cells that utilize CARs and outlines methods for their application. Another notable patent involves modified monocytes/macrophages expressing chimeric antigen receptors, which includes methods and compositions for treating various forms of cancer. By modifying these immune cells, Klichinsky's work aims to recruit them to the tumor microenvironment, allowing them to infiltrate and eliminate target cells effectively.

Career Highlights

Klichinsky has worked with esteemed institutions such as the University of Pennsylvania and Carisma Therapeutics Inc. His innovative research has positioned him as a key figure in the development of advanced cancer therapies.

Collaborations

Throughout his career, Klichinsky has collaborated with notable professionals in the field, including Saar Gill and Carl H. June. These partnerships have further enhanced the impact of his research and inventions.

Conclusion

Michael Klichinsky's work exemplifies the intersection of innovation and medical science, particularly in the fight against cancer. His patents and collaborations reflect a commitment to advancing therapeutic strategies that harness the power of the immune system.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…